Trademarks = 2

Forward Citations = 5

Loading Chart...

8 inventors (with patents filed for the assignee):

George Guikai Wu (5 out of 5 patents)

Yonglei Shang (3 out of 3 patents)

Per Niklas Hedde (2 out of 3 patents)

4. Hamed Shadpour (2 out of 5 patents)

5. Guikai Wu (1 out of 1 patent)

6. Aude I Segaliny (1 out of 1 patent)

7. Xianzhi Jiang (1 out of 1 patent)

8. Xiaoya Ma (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12510535 - COMPARTMENTALIZED ASSAYS OF BISPECIFIC AND MULTISPECIFIC BIOLOGICS (2025-12-30),

2. 12227574 - Anti-CD3 constructs and uses thereof (2025-02-18),

3. 11913939 - Compartmentalized assays of bispecific and multispecific biologics (2024-02-27),

4. 11059044 - Microfluidic determination of low abundance events (2021-07-13),

5. 10960394 - Microfluidic determination of low abundance events (2021-03-30),

6. 10684212 - Method and system for reference-assisted droplet detection, indexing and sorting for assays and diagnostics (2020-06-16),

Company Overview

Amberstone Biosciences, Inc. is a leading biotechnology company focused on developing innovative therapies for cancer and other diseases. With a strong emphasis on research and development, Amberstone is dedicated to improving patient outcomes through cutting-edge scientific advancements. The company's portfolio includes novel drug candidates and diagnostic tools aimed at addressing unmet medical needs in the field of oncology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

6 Patents

#20 in Laguna Hills, CA

#10,565 in California

#44,949 in US

Laguna Hills, CA, United States of America

Amberstone Biosciences, Inc.

Forward Citations = 5

8 inventors:

George Guikai Wu (5 out of 5 patents)

Yonglei Shang (3 out of 3 patents)

Per Niklas Hedde (2 out of 3 patents)

4. Hamed Shadpour (2 out of 5 patents)

5. Guikai Wu (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Amberstone Biosciences, Inc.. Retrieved from https://idiyas.com/company/amberstone-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]